Matches in SemOpenAlex for { <https://semopenalex.org/work/W2079517309> ?p ?o ?g. }
- W2079517309 endingPage "385" @default.
- W2079517309 startingPage "375" @default.
- W2079517309 abstract "Enfuvirtide (T-20) is the first entry inhibitor approved for treatment of HIV infection and acts by inhibiting conformational changes in the viral envelope protein gp41 that are necessary for fusion of the virus and host cell membranes. Here we present genotypic and phenotypic data on viral envelopes obtained at baseline (n = 627) and after 48 weeks of enfuvirtide treatment (n = 302) from patients in the TORO (T-20 versus Optimized Regimen Only)-1 and -2 phase III pivotal studies. The amino acid sequence at residues 36-45 of gp41 was highly conserved at baseline except for polymorphism of approximately 16% at position 42. Substitutions within gp41 residues 36-45 on treatment were observed in virus from 92.7% of patients who met protocol defined virological failure criteria and occurred in nearly all cases (98.8%) when decreases in susceptibility to enfuvirtide from baseline of greater than 4-fold were observed. Consistent with previous observations, a wide range of baseline susceptibilities (spanning 3 logs) was observed; however, lower in vitro baseline susceptibility was not significantly associated with a decreased virological response in vivo. Virological response was also independent of baseline coreceptor tropism and viral subtype." @default.
- W2079517309 created "2016-06-24" @default.
- W2079517309 creator A5003987956 @default.
- W2079517309 creator A5007050525 @default.
- W2079517309 creator A5023660900 @default.
- W2079517309 creator A5028155919 @default.
- W2079517309 creator A5035336361 @default.
- W2079517309 creator A5075185353 @default.
- W2079517309 creator A5079802450 @default.
- W2079517309 creator A5082294399 @default.
- W2079517309 creator A5082773746 @default.
- W2079517309 creator A5083712041 @default.
- W2079517309 date "2006-05-01" @default.
- W2079517309 modified "2023-09-25" @default.
- W2079517309 title "Characterization of Envelope Glycoprotein gp41 Genotype and Phenotypic Susceptibility to Enfuvirtide at Baseline and on Treatment in the Phase III Clinical Trials TORO-1 and TORO-2" @default.
- W2079517309 cites W1537640815 @default.
- W2079517309 cites W1542320852 @default.
- W2079517309 cites W15969640 @default.
- W2079517309 cites W191242174 @default.
- W2079517309 cites W1965987174 @default.
- W2079517309 cites W2010387580 @default.
- W2079517309 cites W2011483956 @default.
- W2079517309 cites W2016718862 @default.
- W2079517309 cites W2023270608 @default.
- W2079517309 cites W2029052791 @default.
- W2079517309 cites W2033757712 @default.
- W2079517309 cites W2034073194 @default.
- W2079517309 cites W2040506631 @default.
- W2079517309 cites W2041505318 @default.
- W2079517309 cites W2048336729 @default.
- W2079517309 cites W2050621055 @default.
- W2079517309 cites W2064469588 @default.
- W2079517309 cites W2082363533 @default.
- W2079517309 cites W2085739552 @default.
- W2079517309 cites W2100086384 @default.
- W2079517309 cites W2106882534 @default.
- W2079517309 cites W2111610276 @default.
- W2079517309 cites W2112129496 @default.
- W2079517309 cites W2120064320 @default.
- W2079517309 cites W2123797944 @default.
- W2079517309 cites W2128574780 @default.
- W2079517309 cites W2133649749 @default.
- W2079517309 cites W2146478787 @default.
- W2079517309 cites W2148591835 @default.
- W2079517309 cites W2153747683 @default.
- W2079517309 cites W2158873843 @default.
- W2079517309 cites W2169561386 @default.
- W2079517309 cites W2172198911 @default.
- W2079517309 cites W2177879277 @default.
- W2079517309 cites W2916542119 @default.
- W2079517309 doi "https://doi.org/10.1089/aid.2006.22.375" @default.
- W2079517309 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16706613" @default.
- W2079517309 hasPublicationYear "2006" @default.
- W2079517309 type Work @default.
- W2079517309 sameAs 2079517309 @default.
- W2079517309 citedByCount "65" @default.
- W2079517309 countsByYear W20795173092012 @default.
- W2079517309 countsByYear W20795173092013 @default.
- W2079517309 countsByYear W20795173092014 @default.
- W2079517309 countsByYear W20795173092016 @default.
- W2079517309 countsByYear W20795173092017 @default.
- W2079517309 countsByYear W20795173092018 @default.
- W2079517309 countsByYear W20795173092019 @default.
- W2079517309 countsByYear W20795173092021 @default.
- W2079517309 countsByYear W20795173092022 @default.
- W2079517309 crossrefType "journal-article" @default.
- W2079517309 hasAuthorship W2079517309A5003987956 @default.
- W2079517309 hasAuthorship W2079517309A5007050525 @default.
- W2079517309 hasAuthorship W2079517309A5023660900 @default.
- W2079517309 hasAuthorship W2079517309A5028155919 @default.
- W2079517309 hasAuthorship W2079517309A5035336361 @default.
- W2079517309 hasAuthorship W2079517309A5075185353 @default.
- W2079517309 hasAuthorship W2079517309A5079802450 @default.
- W2079517309 hasAuthorship W2079517309A5082294399 @default.
- W2079517309 hasAuthorship W2079517309A5082773746 @default.
- W2079517309 hasAuthorship W2079517309A5083712041 @default.
- W2079517309 hasConcept C104317684 @default.
- W2079517309 hasConcept C108625454 @default.
- W2079517309 hasConcept C135763542 @default.
- W2079517309 hasConcept C153911025 @default.
- W2079517309 hasConcept C159047783 @default.
- W2079517309 hasConcept C159654299 @default.
- W2079517309 hasConcept C195616568 @default.
- W2079517309 hasConcept C203014093 @default.
- W2079517309 hasConcept C2776258796 @default.
- W2079517309 hasConcept C2778037500 @default.
- W2079517309 hasConcept C2778899366 @default.
- W2079517309 hasConcept C3013748606 @default.
- W2079517309 hasConcept C54355233 @default.
- W2079517309 hasConcept C86803240 @default.
- W2079517309 hasConceptScore W2079517309C104317684 @default.
- W2079517309 hasConceptScore W2079517309C108625454 @default.
- W2079517309 hasConceptScore W2079517309C135763542 @default.
- W2079517309 hasConceptScore W2079517309C153911025 @default.
- W2079517309 hasConceptScore W2079517309C159047783 @default.
- W2079517309 hasConceptScore W2079517309C159654299 @default.
- W2079517309 hasConceptScore W2079517309C195616568 @default.
- W2079517309 hasConceptScore W2079517309C203014093 @default.